The three main tumor markers doctors use to diagnose NSCLC are CYFRA21-1, CEA, and SCC-Ag. Additionally, research from 2018 found that a panel that includes testing for PRL, CEA, and CYFRA21-1 was ...

and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to ...

and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to ...

The following is a summary of “Collagen turnover biomarkers to predict outcome of patients with biliary cancer,” published in ...

[14] To evaluate biliary strictures of undetermined etiology, the efficacies of variable diagnostic impetuses such as tumor markers, radiological evaluations, endoscopic approaches and tissue ...

The different methylation patterns between Normal and Tumor were also quite evident (Figure s3B-C ... combine the cfDNA methylation model with clinically commonly used markers such as CEA and CA19-9.

and serum tumor markers [carcinoembryonic antigen (CEA), cytokeratin fraction 21-1 (CYFRA 21-1), squamous cell carcinoma antigen (SCC), and neuron-specific enolase (NSE)]. Clinical characteristics ...

However, few studies have compared the efficacy of existing blood inflammatory markers in predicting the prognosis of patients with locally advanced gastric cancer in combination ... CA72-4, and CEA ...

Biomarkers to assist in evaluating some cancers (tumor markers) have also been used for a long time ... Examples include C-reactive protein (CRP), carcinoembryonic antigen (CEA), and ...

Early detection of gastric cancer (GC) can help patients receive timely ... And some information of peripheral blood tumour markers, including carcinoembryonic antigen (CEA), carbohydrate antigen 242 ...